North America Precision Diagnostics Market Size, Share & Trends Analysis Report By End-use, By Type, By Application (Oncology, Respiratory Diseases, CNS Disorders, Immunology, Skin Diseases, Genetic Diseases, and Others), By Country and Growth Forecast, 2024 - 2031

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Precision Diagnostics Market, by End-use
1.4.2 North America Precision Diagnostics Market, by Type
1.4.3 North America Precision Diagnostics Market, by Application
1.4.4 North America Precision Diagnostics Market, by Country
1.5 Methodology for the research

2.1 Key Highlights

3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges

4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2020-2024)
4.3.2 Key Strategic Move: (Partnerships, Collaborations & Agreements: 2021, Jul - 2024, May) Leading Players
4.4 Porter Five Forces Analysis

5.1 North America Clinical Laboratories Market by Country
5.2 North America Hospitals Market by Country
5.3 North America Others Market by Country

6.1 North America Genetic Tests Market by Country
6.2 North America Esoteric Tests Market by Country
6.3 North America Direct to Consumer Tests Market by Country
6.4 North America Others Market by Country

7.1 North America Oncology Market by Country
7.2 North America Respiratory Diseases Market by Country
7.3 North America CNS Disorders Market by Country
7.4 North America Immunology Market by Country
7.5 North America Skin Diseases Market by Country
7.6 North America Genetic Diseases Market by Country
7.7 North America Others Market by Country

8.1 US Precision Diagnostics Market
8.1.1 US Precision Diagnostics Market by End-use
8.1.2 US Precision Diagnostics Market by Type
8.1.3 US Precision Diagnostics Market by Application
8.2 Canada Precision Diagnostics Market
8.2.1 Canada Precision Diagnostics Market by End-use
8.2.2 Canada Precision Diagnostics Market by Type
8.2.3 Canada Precision Diagnostics Market by Application
8.3 Mexico Precision Diagnostics Market
8.3.1 Mexico Precision Diagnostics Market by End-use
8.3.2 Mexico Precision Diagnostics Market by Type
8.3.3 Mexico Precision Diagnostics Market by Application
8.4 Rest of North America Precision Diagnostics Market
8.4.1 Rest of North America Precision Diagnostics Market by End-use
8.4.2 Rest of North America Precision Diagnostics Market by Type
8.4.3 Rest of North America Precision Diagnostics Market by Application

9.1 Abbott Laboratories
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 F. Hoffmann-La Roche Ltd.
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Partnerships, Collaborations, and Agreements:
9.2.5.2 Product Launches and Product Expansions:
9.2.6 SWOT Analysis
9.3 Siemens Healthineers AG (Siemens AG)
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 Recent strategies and developments:
9.3.5.1 Partnerships, Collaborations, and Agreements:
9.3.5.2 Product Launches and Product Expansions:
9.3.5.3 Acquisition and Mergers:
9.3.6 SWOT Analysis
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Partnerships, Collaborations, and Agreements:
9.4.6 SWOT Analysis
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.6 SWOT Analysis
9.6 Agilent Technologies, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.6.6 SWOT Analysis
9.7 BioMerieux S.A.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Partnerships, Collaborations, and Agreements:
9.7.5.2 Acquisition and Mergers:
9.7.6 SWOT Analysis
9.8 Becton, Dickinson, and Company
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 SWOT Analysis
9.9 Qiagen N.V.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
9.9.5 Recent strategies and developments:
9.9.5.1 Partnerships, Collaborations, and Agreements:
9.9.5.2 Product Launches and Product Expansions:
9.9.6 SWOT Analysis
9.10. Hologic, Inc.
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expenses
9.10.5 SWOT Analysis